PFM
HAE icon

Premier Fund Managers’s Haemonetics HAE Stock Holding History

Premier Fund Managers’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Hold
3,702
– – 0.03% 143
2026
Q1 		$203K Buy
+3,702
New +$241K 0.01% 148
2021
Q2 		– Sell
-31,342
Closed -$3.52M – 227
2021
Q1 		$3.52M Buy
+31,342
New +$3.88M 0.14% 144

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Premier Fund Managers's HAE Position: Q2 2026 in Review

Premier Fund Managers held its Haemonetics (HAE) position steady in Q2 2026 at 3,702 shares worth $278K. The position accounts for 0.03% of the portfolio, ranked #143.

Premier Fund Managers first reported a position in HAE in Q1 2021 and has held it in 3 quarters since. The position peaked at $3.52M in Q1 2021. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Premier Fund Managers held 3,702 shares of Haemonetics worth $278K as of Q2 2026.
  • Premier Fund Managers left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up 0.03% of Premier Fund Managers's portfolio in Q2 2026, its #143 holding.
  • Premier Fund Managers first reported a position in Haemonetics in Q1 2021 and has held it in 3 quarters since.
  • Premier Fund Managers's Haemonetics position peaked at $3.52M in Q1 2021.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.